Abbott Laboratories received its second Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) to produce a coronavirus antibody test, according to a statement by Abbott on Monday.
Abbott said the company plans to ship its serology-based blood test on the Alinity i system with nearly 30 million antibody tests globally in May and “capacity for 60 million tests in June.”
“Having more options of highly reliable tests across our platforms will help healthcare workers and health officials as they conduct broad scale testing for Covid-19," said Robert Ford, Abbott’s president and chief executive officer.
The first serology test by Abbott was approved for an EUA on April 26 and runs on Abbott’s ARCHITECT system.
The EUA has not posted to the FDA website at this time. CNN has reached out to the FDA, but has not heard back.